Patel Prashant 4

What Happened

• Prashant Patel, CEO of Wellgistics Health, exercised warrants and acquired a total of 200,000 shares on June 22, 2026. The filings show two in‑the‑money derivative exercises: 100,000 shares at $0.01 (cost $500) and 100,000 shares at $0.00 (no cash paid), for an aggregate cash outlay of $500. These were acquisitions (not sales).

Key Details

• Transaction date: June 22, 2026.
• Exercise details: 100,000 shares @ $0.01 (paid $500); 100,000 shares @ $0.00 (no cash).
• Total acquired: 200,000 shares for $500.
• Footnote F1: These shares reflect conversion/exercise of warrants issued to Patel on 3/31/2026 in lieu of cash compensation.
• Footnote F2: The reported holdings reflect the issuer’s reverse stock split (effective May 26, 2026) and the shares issued on conversion; the filing aggregates post‑split holdings.
• Filing date: June 25, 2026 — three days after the transaction date, which appears to be later than the typical two‑business‑day Form 4 deadline.

Context

• This was an exercise/conversion of warrants (derivative securities) into common stock, not an immediate sale — the shares were acquired and not reported as sold in this filing. Exercises and conversions often reflect compensation arrangements (here, warrants issued instead of cash). The reverse stock split can change reported share counts; refer to the company filing for exact post‑split totals.